Frank Jessen
#136,466
Most Influential Person Now
Researcher
Frank Jessen's AcademicInfluence.com Rankings
Frank Jessenphilosophy Degrees
Philosophy
#6913
World Rank
#10035
Historical Rank
Logic
#4001
World Rank
#5241
Historical Rank

Frank Jessenbiology Degrees
Biology
#9397
World Rank
#12598
Historical Rank
Neuroscience
#1370
World Rank
#1417
Historical Rank

Download Badge
Philosophy Biology
Frank Jessen's Degrees
- PhD Neuroscience University of Cologne
- Doctorate Medicine University of Cologne
Why Is Frank Jessen Influential?
(Suggest an Edit or Addition)Frank Jessen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease (2018) (4523)
- Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease (2011) (1701)
- Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease (2009) (1644)
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease (2014) (1634)
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes (2009) (1441)
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2013) (1388)
- Defeating Alzheimer's disease and other dementias: a priority for European science and society (2016) (1172)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives (2010) (616)
- Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease (2010) (587)
- Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. (2010) (572)
- AD dementia risk in late MCI, in early MCI, and in subjective memory impairment (2014) (401)
- The characterisation of subjective cognitive decline (2020) (383)
- Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. (2000) (375)
- Implementation of subjective cognitive decline criteria in research studies (2017) (333)
- Validity of the five-item WHO Well-Being Index (WHO-5) in an elderly population (2009) (331)
- Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies. (2015) (296)
- Common variants at ABCA 7 , MS 4 A 6 A / MS 4 A 4 E , EPHA 1 , CD 33 and CD 2 AP are associated with Alzheimer ’ s disease (2011) (292)
- Nitration of Tyrosine 10 Critically Enhances Amyloid β Aggregation and Plaque Formation (2011) (263)
- A Pan-European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats (2012) (254)
- Volume reduction of the entorhinal cortex in subjective memory impairment (2006) (249)
- New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) (246)
- Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors (2012) (227)
- 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. (2002) (223)
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry (2017) (209)
- The future of Alzheimer's disease: The next 10 years (2011) (203)
- Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho‐Tau in patients with low‐ and high‐CSF Aβ40 load (2007) (198)
- Risk of dementia in elderly patients with the use of proton pump inhibitors (2015) (193)
- A genetic variation of the inflammatory cytokine interleukin‐6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease (1999) (193)
- The Concreteness Effect: Evidence for Dual Coding and Context Availability (2000) (191)
- Mild Cognitive Impairment in General Practice: Age-Specific Prevalence and Correlate Results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe) (2007) (189)
- Subjective cognitive decline and rates of incident Alzheimer’s disease and non-Alzheimer’s disease dementia (2018) (188)
- Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial (2013) (178)
- Deep Brain Stimulation for Tourette-Syndrome: A Systematic Review and Meta-Analysis (2016) (173)
- Prevalence and risk factors for depression in non-demented primary care attenders aged 75 years and older. (2008) (173)
- Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study (2010) (173)
- Convergent genetic and expression data implicate immunity in Alzheimer's disease (2014) (172)
- Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD (2000) (164)
- Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding (2007) (158)
- Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease (2012) (158)
- Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies. (2007) (157)
- Volume Loss of the Medial Temporal Lobe Structures in Subjective Memory Impairment (2010) (155)
- Plasma 24S‐hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease (2000) (153)
- Patterns of subjective memory impairment in the elderly: association with memory performance (2007) (144)
- Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment (2012) (142)
- Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response. (2009) (138)
- Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease (2002) (138)
- Glucose metabolism, gray matter structure and memory decline in subjective memory impairment (2012) (136)
- Evidence of neuronal compensation during episodic memory in subjective memory impairment. (2011) (134)
- Longitudinal Predictors of Institutionalization in Old Age (2015) (134)
- Prediction of Dementia in Primary Care Patients (2011) (130)
- Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type (2015) (129)
- Gray matter atrophy pattern in elderly with subjective memory impairment (2014) (129)
- A peripheral epigenetic signature of immune system genes is linked to neocortical thickness and memory (2017) (126)
- Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer's disease. (2001) (122)
- CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study (2015) (119)
- Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients. (2003) (119)
- Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load. (2007) (115)
- KIBRA gene variants are associated with episodic memory in healthy elderly (2008) (111)
- Cognitive performance before and after the onset of subjective cognitive decline in old age (2015) (110)
- Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE) (2018) (109)
- Multicenter assessment of reliability of cranial MRI (2006) (108)
- Amplitude reduction of the mismatch negativity in first-degree relatives of patients with schizophrenia (2001) (107)
- Evidence for an association between KIBRA and late-onset Alzheimer's disease (2010) (105)
- Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer’s disease (2014) (105)
- DNA sequence variants of the FKBP5 gene are associated with unipolar depression. (2010) (104)
- Multicenter stability of diffusion tensor imaging measures: A European clinical and physical phantom study (2011) (103)
- Anticholinergic drug use and risk for dementia: target for dementia prevention (2010) (102)
- Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study (2008) (101)
- Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing (2010) (101)
- Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke (2004) (101)
- Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction (2006) (101)
- Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease (2020) (98)
- Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease. (2013) (96)
- Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy (2020) (94)
- Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease (2013) (93)
- Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration (2014) (93)
- Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene (2014) (92)
- S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease (2010) (90)
- In vivo MRI assessment of the human locus coeruleus along its rostrocaudal extent in young and older adults (2017) (89)
- Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients (2001) (89)
- Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment (2009) (88)
- Non-Pharmacologic Interventions for Older Adults with Subjective Cognitive Decline: Systematic Review, Meta-Analysis, and Preliminary Recommendations (2017) (88)
- Converging Genetic and Functional Brain Imaging Evidence Links Neuronal Excitability to Working Memory, Psychiatric Disease, and Brain Activity (2014) (86)
- In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease. (2016) (86)
- Age-related functional changes in domain-specific medial temporal lobe pathways (2018) (86)
- Apart from nihilism and stigma: what influences general practitioners' accuracy in identifying incident dementia? (2009) (86)
- Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment (2016) (86)
- TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2017) (85)
- Neural correlates of verbal episodic memory in patients with MCI and Alzheimer's disease––a VBM study (2008) (85)
- Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2021) (85)
- Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease (1999) (83)
- In-vivo proton MR-spectroscopy of the human brain: Assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration (2002) (83)
- Resting-state perfusion in nonmedicated schizophrenic patients: a continuous arterial spin-labeling 3.0-T MR study. (2010) (81)
- METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research (2016) (81)
- Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease (2016) (80)
- A multicenter 1H-MRS study of the medial temporal lobe in AD and MCI (2009) (80)
- Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene–environment interaction for the risk of dementia and Alzheimer's disease dementia (2013) (79)
- APOA1 polymorphism influences risk for early‐onset nonfamiliar AD (2005) (79)
- Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease (2020) (78)
- Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state (2008) (78)
- Activation of human language processing brain regions after the presentation of random letter strings demonstrated with event-related functional magnetic resonance imaging (1999) (77)
- CSF cortisol in Alzheimer's disease and mild cognitive impairment (2009) (77)
- The Role of Macrophage Migration Inhibitory Factor in Alzheimer’s Disease (2010) (75)
- Treatment monitoring and response prediction with proton MR spectroscopy in AD (2006) (74)
- Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia (2006) (74)
- ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia (2005) (74)
- Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease. (2009) (73)
- Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population (2000) (72)
- Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease (2018) (71)
- Predicting behavioral variant frontotemporal dementia with pattern classification in multi-center structural MRI data (2017) (70)
- Prognosis of Mild Cognitive Impairment in General Practice: Results of the German AgeCoDe Study (2014) (70)
- Early-Onset and Late-Onset Depression Are Independent of the Genetic Polymorphism of Apolipoprotein E (1999) (69)
- Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer (2017) (69)
- Subjective Cognitive Decline (2015) (68)
- Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease. (2002) (67)
- Unipolar depression and hippocampal volume: Impact of DNA sequence variants of the glucocorticoid receptor gene (2008) (67)
- N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia. (2013) (66)
- Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study (2019) (66)
- Abnormal Resting-State Functional Connectivity Strength in Mild Cognitive Impairment and Its Conversion to Alzheimer's Disease (2015) (65)
- Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2009) (64)
- Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease (2012) (64)
- The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey (2015) (64)
- New insights on the genetic etiology of Alzheimer’s and related dementia (2020) (64)
- Smoking upregulates α4β2* nicotinic acetylcholine receptors in the human brain (2008) (63)
- Cortical thinning in individuals with subjective memory impairment. (2015) (62)
- Mild cognitive impairment (MCI) and actual retrieval performance affect cerebral activation in the elderly (2007) (62)
- Incident subjective memory complaints and the risk of subsequent dementia (2015) (62)
- The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. (2012) (61)
- Predictors of frailty in old age–results of a longitudinal study (2015) (61)
- Locus coeruleus MRI contrast is reduced in Alzheimer's disease dementia and correlates with CSF Aβ levels (2019) (61)
- A multicentre RCT on community occupational therapy in Alzheimer's disease: 10 sessions are not better than one consultation (2011) (60)
- Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia (2017) (60)
- Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment. (2017) (59)
- Prediction of incident dementia: impact of impairment in instrumental activities of daily living and mild cognitive impairment-results from the German study on ageing, cognition, and dementia in primary care patients. (2012) (59)
- Mrp14 Deficiency Ameliorates Amyloid β Burden by Increasing Microglial Phagocytosis and Modulation of Amyloid Precursor Protein Processing (2012) (59)
- A family study of Alzheimer disease and early- and late-onset depression in elderly patients. (2001) (58)
- Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease. (2009) (58)
- The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy. (2014) (57)
- Alterations of cholesterol precursor levels in Alzheimer's disease. (2010) (57)
- Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease (2018) (57)
- Association of SORL1 gene variants with Alzheimer's disease (2009) (56)
- Genome-Wide Association Study of Vascular Dementia (2012) (56)
- Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease (2010) (56)
- Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume (2011) (56)
- Predictors of Costs in Dementia in a Longitudinal Perspective (2013) (56)
- Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood (2019) (55)
- PLD3 in non-familial Alzheimer's disease (2015) (54)
- The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study. (2013) (53)
- Association of the Alzheimer's disease clusterin risk allele with plasma clusterin concentration. (2011) (53)
- Do general practitioners recognize mild cognitive impairment in their patients? (2010) (52)
- Prospective Associations between Single Foods, Alzheimer’s Dementia and Memory Decline in the Elderly (2018) (50)
- No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression (2009) (49)
- Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism (2013) (49)
- Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease (2014) (49)
- Hippocampal Surface Analysis in Subjective Memory Impairment, Mild Cognitive Impairment and Alzheimer’s Dementia (2008) (48)
- A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI (2012) (47)
- The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease (2019) (46)
- Cerebrospinal fluid soluble amyloid-β protein precursor as a potential novel biomarkers of Alzheimer's disease. (2012) (46)
- Longitudinal predictors of informal and formal caregiving time in community-dwelling dementia patients (2016) (45)
- Predictors of Institutionalisation in Incident Dementia – Results of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe Study) (2012) (45)
- Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings. (2011) (44)
- Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. (2022) (44)
- Elevated HbA1c is associated with increased risk of incident dementia in primary care patients. (2015) (44)
- Differential Risk of Incident Alzheimer's Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline. (2016) (44)
- N-acetyl-aspartate (NAA) as a correlate of pharmacological treatment in psychiatric disorders: A systematic review (2014) (43)
- Functional MRI of cerebral activation during encoding and retrieval of words (1999) (42)
- Engineered antibodies: new possibilities for brain PET? (2019) (42)
- Anatomical correlates of the neuropsychiatric symptoms in Alzheimer's disease. (2015) (42)
- Influence of Sampling and Recruitment Methods in Studies of Subjective Cognitive Decline. (2015) (41)
- The plant sterol brassicasterol as additional CSF biomarker in Alzheimer’s disease (2011) (41)
- SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease. (2014) (41)
- Feature Binding Deficits in Subjective Cognitive Decline and in Mild Cognitive Impairment. (2015) (41)
- Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment (2014) (40)
- Influence of SORL1 gene variants: Association with CSF amyloid-β products in probable Alzheimer's disease (2008) (40)
- Higher CSF Tau Levels Are Related to Hippocampal Hyperactivity and Object Mnemonic Discrimination in Older Adults (2019) (40)
- Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI (2015) (40)
- Successful treatment of sexual disinhibition in dementia with carbamazepine -- a case report. (2005) (39)
- CYP46A1 variants influence Alzheimer’s disease risk and brain cholesterol metabolism (2009) (39)
- Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment (2016) (39)
- Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson’s Disease (2015) (39)
- Estimating prevalence of subjective cognitive decline in and across international cohort studies of aging: a COSMIC study (2020) (39)
- Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes (2014) (38)
- The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk (2014) (38)
- Neuroanatomical Characteristics Associated With Response to Deep Brain Stimulation of the Nucleus Basalis of Meynert for Alzheimer's Disease (2018) (37)
- Gene polymorphisms in prodynorphin (PDYN) are associated with episodic memory in the elderly (2009) (37)
- Anterior hippocampus orchestrates successful encoding and retrieval of non-relational memory: an event-related fMRI study (2008) (36)
- Reduced future-oriented decision making in individuals with subjective cognitive decline: A functional MRI study (2017) (36)
- Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease (2000) (36)
- Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing (2018) (36)
- Predicting primary progressive aphasias with support vector machine approaches in structural MRI data (2017) (36)
- A hierarchy of predictors for dementia‐free survival in old‐age: results of the AgeCoDe study (2014) (35)
- Lifetime depressive and somatic symptoms as preclinical markers of late-onset depression (2003) (35)
- Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age (2021) (34)
- The costs of dementia from the societal perspective: is care provided in the community really cheaper than nursing home care? (2014) (34)
- Is function in instrumental activities of daily living a useful feature in predicting Alzheimer's disease dementia in subjective cognitive decline? (2018) (34)
- Caspase-8, association with Alzheimer’s Disease and functional analysis of rare variants (2017) (34)
- PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment (2020) (34)
- A genome-wide survey of human short-term memory (2009) (34)
- PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment (2020) (34)
- Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease‐modifying therapies (2020) (33)
- Risk factors and early signs of Alzheimer's disease in a family study sample (2006) (33)
- Association of an interleukin-1β gene polymorphism at position -511 with Alzheimer's disease (2003) (33)
- Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline. (2015) (33)
- RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolism (2009) (32)
- Predictors of hippocampal atrophy in critically ill patients (2015) (32)
- Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease (2003) (32)
- Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment. (2017) (32)
- Cerebrospinal fluid markers for Alzheimer's disease over the lifespan: effects of age and the APOEε4 genotype. (2010) (32)
- [Potentially inappropriate medication in elderly primary care patients : A retrospective, longitudinal analysis]. (2013) (32)
- Verbal Memory Deficits Are Correlated with Prefrontal Hypometabolism in 18FDG PET of Recreational MDMA Users (2013) (32)
- Smoking upregulates alpha4beta2* nicotinic acetylcholine receptors in the human brain. (2008) (31)
- A multicenter reproducibility study of single-voxel 1H-MRS of the medial temporal lobe (2006) (31)
- Long-term stability of Alzheimer's disease biomarker proteins in cerebrospinal fluid. (2011) (31)
- Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer's disease. (2012) (30)
- A Comparative Study of the Different N-Acetylaspartate Measures of the Medial Temporal Lobe in Alzheimer’s Disease (2005) (30)
- DNA Methylation of the TNF-α Promoter Region in Peripheral Blood Monocytes and the Cortex of Human Alzheimer's Disease Patients (2014) (30)
- Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's disease (2015) (29)
- Which types of mental work demands may be associated with reduced risk of dementia? (2017) (29)
- Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease—Data from three memory clinic studies (2018) (29)
- A Modified Reading the Mind in the Eyes Test Predicts Behavioral Variant Frontotemporal Dementia Better Than Executive Function Tests (2018) (29)
- Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD) (2018) (29)
- Highly efficient yellow organic light emitting diode based on a layer-cross faded emission layer allowing easy color tuning (2009) (29)
- The influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease (2015) (29)
- Minor neuropsychological deficits in patients with subjective cognitive decline (2020) (29)
- Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease based on multicenter diffusion tensor imaging (2018) (28)
- Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples (2019) (28)
- Personalized risk for clinical progression in cognitively normal subjects—the ABIDE project (2019) (28)
- Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury (2020) (28)
- Allelic association between the D10S1423 marker and Alzheimer's disease in a German population (2000) (27)
- Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patients (2020) (27)
- Subjective cognitive decline is longitudinally associated with lower health-related quality of life (2017) (27)
- Is the Clock Drawing Test Appropriate for Screening for Mild Cognitive Impairment? – Results of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe) (2009) (27)
- AMYPAD Diagnostic and Patient Management Study: Rationale and design (2018) (27)
- Cerebrospinal fluid levels of &bgr;-amyloid(42) in patients with Alzheimer's disease are related to the exon 2 polymorphism of the cathepsin D gene (2002) (27)
- Tau plasma levels in subjective cognitive decline: Results from the DELCODE study (2017) (26)
- CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk (2008) (26)
- [Diagnostic lumbar puncture performed in the outpatient setting of a memory clinic. Frequency and risk factors of post-lumbar puncture headache]. (2007) (26)
- Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease (2019) (26)
- Successful Verbal Retrieval in Elderly Subjects Is Related to Concurrent Hippocampal and Posterior Cingulate Activation (2006) (26)
- Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluid (2012) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Novelty detection and repetition suppression in a passive picture viewing task: A possible approach for the evaluation of neuropsychiatric disorders (2002) (25)
- Impact of coronary heart disease on cognitive decline in Alzheimer's disease: a prospective longitudinal cohort study in primary care. (2017) (25)
- Association of amygdala volumes with cortisol secretion in unipolar depressed patients (2012) (25)
- A Reduction in Delay Discounting by Using Episodic Future Imagination and the Association with Episodic Memory Capacity (2017) (25)
- Human genome–guided identification of memory-modulating drugs (2013) (25)
- Left anterior temporal lobe sustains naming in Alzheimer's dementia and mild cognitive impairment. (2011) (25)
- Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection (2018) (25)
- Mortality in incident dementia – results from the German Study on Aging, Cognition, and Dementia in Primary Care Patients (2015) (24)
- Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease. (2006) (24)
- Response-related fMRI of veridical and false recognition of words (2004) (24)
- General practitioners’ views on (long-term) prescription and use of problematic and potentially inappropriate medication for oldest-old patients—A qualitative interview study with GPs (CIM-TRIAD study) (2017) (23)
- The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment. (2015) (23)
- CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume (2018) (22)
- Mortality in Individuals with Subjective Cognitive Decline: Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). (2015) (22)
- The SCD-Well randomized controlled trial: Effects of a mindfulness-based intervention versus health education on mental health in patients with subjective cognitive decline (SCD) (2018) (22)
- Complex coevolution of depression and health-related quality of life in old age (2015) (22)
- Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated form. (2009) (22)
- Genetic Analysis of Association Between Calcium Signaling and Hippocampal Activation, Memory Performance in the Young and Old, and Risk for Sporadic Alzheimer Disease. (2015) (21)
- Neuronal correlates of delay discounting in healthy subjects and its implication for addiction: an ALE meta-analysis study (2019) (21)
- “Alzheimer's disease” is neither “Alzheimer's clinical syndrome” nor “dementia” (2019) (21)
- Effects of deep brain stimulation on prepulse inhibition in obsessive-compulsive disorder (2015) (21)
- Interindividual variation of cerebral activation during encoding and retrieval of words (2000) (21)
- Stress and Alzheimer’s disease (2019) (20)
- Advance directives and power of attorney for health care in the oldest-old – results of the AgeQualiDe study (2017) (20)
- Computational dissection of human episodic memory reveals mental process-specific genetic profiles (2015) (20)
- Differential risk of incident Alzheimer's disease dementia in stable versus unstable patterns of subjective cognitive decline (2015) (19)
- Gene variations in GSTM3 are a risk factor for Alzheimer's disease (2009) (19)
- Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 (2021) (19)
- Unmet Care Needs in the Oldest Old Primary Care Patients with Cognitive Disorders: Results of the AgeCoDe and AgeQualiDe Study (2017) (19)
- Dietary patterns are related to cognitive functioning in elderly enriched with individuals at increased risk for Alzheimer’s disease (2020) (19)
- Effect of Cardiovascular and Metabolic Disease on Cognitive Test Performance and Cognitive Change in Older Adults (2012) (18)
- TBK 1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2019) (18)
- Encoding and retrieval related cerebral activation in continuous verbal recognition. (2001) (18)
- Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study (2020) (18)
- Subjective cognitive decline and subsequent dementia: a nationwide cohort study of 579,710 people aged 66 years in South Korea (2020) (18)
- Identical distribution of the alpha 2-macroglobulin pentanucleotide deletion in subjects with Alzheimer disease and controls in a German population. (2000) (18)
- Response-related fMRI analysis during encoding and retrieval revealed differences in cerebral activation by retrieval success (2000) (18)
- Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers (2019) (18)
- PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease (2006) (18)
- Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment (2019) (17)
- Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study (2015) (17)
- Differences of cerebral activation between superior and inferior learners during motor sequence encoding and retrieval (2004) (17)
- Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease (2020) (17)
- Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET (2021) (17)
- Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 (2021) (16)
- Incident Subjective Cognitive Decline Does Not Predict Mortality in the Elderly – Results from the Longitudinal German Study on Ageing, Cognition, and Dementia (AgeCoDe) (2016) (16)
- One-Stop Shop: 18F-Flortaucipir PET Differentiates Amyloid-Positive and -Negative Forms of Neurodegenerative Diseases (2020) (16)
- A microRNA signature that correlates with cognition and is a target against cognitive decline (2021) (16)
- [CERAD-NP battery: Age-, gender- and education-specific reference values for selected subtests. Results of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)]. (2009) (15)
- The MOPEAD project: Advancing patient engagement for the detection of “hidden” undiagnosed cases of Alzheimer's disease in the community (2019) (15)
- Association of an interleukin-1beta gene polymorphism at position -511 with Alzheimer's disease. (2003) (15)
- 2017 NIA-AA RESEARCH FRAMEWORK TO INVESTIGATE THE ALZHEIMER’S DISEASE CONTINUUM (2017) (15)
- Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease. (2022) (15)
- Interrelations of Alzheimer´s disease candidate biomarkers neurogranin, fatty acid‐binding protein 3 and ferritin to neurodegeneration and neuroinflammation (2020) (15)
- Correlates of hospitalization among the oldest old: results of the AgeCoDe–AgeQualiDe prospective cohort study (2019) (14)
- Bupropion for the Treatment of Apathy in Alzheimer Disease (2020) (14)
- No association between an intronic biallelic polymorphism of the FE65 gene and Alzheimer's disease. (2000) (14)
- Perspective of elderly patients on chronic use of potentially inappropriate medication – Results of the qualitative CIM-TRIAD study (2018) (14)
- TREM2 rare variant p.R47H is not associated with Parkinson's disease. (2016) (14)
- A simple and fast method for the preparation of n.c.a. 2-[18F]F-A85380 for human use. (2005) (14)
- Multicenter Resting State Functional Connectivity in Prodromal and Dementia Stages of Alzheimer's Disease. (2018) (14)
- Computer-assisted prediction of clinical progression in the earliest stages of AD (2018) (14)
- Association of N-acetylaspartate and cerebrospinal fluid Aβ42 in dementia. (2011) (13)
- Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers (2022) (13)
- Feasibility of short imaging protocols for [18F]PI-2620 tau-PET in progressive supranuclear palsy (2021) (13)
- Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial (2021) (13)
- Risk factors and early signs of Alzheimer's disease in a family study sample. Risk of AD. (2006) (13)
- [Services for the early recognition of psychoses and bipolar disorders in Germany: inventory survey study]. (2015) (13)
- Alpha-1-Antichymotrypsin Gene Polymorphism and Risk for Sporadic Alzheimer’s Disease in a German Population (1999) (13)
- Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes (2018) (13)
- Wishes and preferences for an online lifestyle program for brain health—A mixed methods study (2018) (12)
- Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid Status. (2020) (12)
- Health Literacy in Individuals at Risk for Alzheimer’s Dementia: A Systematic Review (2019) (12)
- APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's disease. (2013) (12)
- Influence of thermal annealing on photoluminescence and structural properties of N,N'-diphenyl-N,N'-bis(1-naphthylphenyl)-1,1'-biphenyl-4,4'-diamine (α-NPD) organic thin films (2007) (12)
- Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study (2020) (12)
- Neurocognitive disorders in ICD‐11: the debate and its outcome (2018) (11)
- Atrophy outcomes in multicentre clinical trials on Alzheimer's disease: Effect of different processing and analysis approaches on sample sizes (2011) (11)
- Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer’s disease (2021) (11)
- Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions (2009) (11)
- Does visual impairment affect social ties in late life? Findings of a multicenter prospective cohort study in Germany (2016) (11)
- No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer disease in a German population (1999) (11)
- Novel genetic matching methods for handling population stratification in genome-wide association studies (2015) (11)
- Gene‐gene interaction between interleukin‐6 and α2‐macroglobulin influences the risk for Alzheimer's disease (2000) (11)
- Inter-rater reliability of family history information on psychiatric disorders in relatives (2001) (10)
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (vol 41, pg 1088, 2009) (2013) (10)
- Polythetic Diagnostic Approach to the Borderline Personality Disorder (2000) (10)
- Eicosapentaenoic Acid Is Associated with Decreased Incidence of Alzheimer’s Dementia in the Oldest Old (2021) (10)
- Informal caregivers’ perspectives on health of and (potentially inappropriate) medication for (relatively) independent oldest-old people – a qualitative interview study (2018) (10)
- Multimodal MRI analysis of basal forebrain structure and function across the Alzheimer’s disease spectrum (2020) (10)
- Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers (2022) (10)
- Growth and characterization of AlGaN/GaN HEMT on SiCOI substrates (2005) (10)
- SUCLG 2 identified as both a determinator of CSF A b 1 – 42 levels and an attenuator of cognitive decline in Alzheimer ’ s disease (2014) (10)
- Characteristics of subjective cognitive decline associated with amyloid positivity (2021) (10)
- Cognitive behavioural therapy for the treatment of late life depression: study protocol of a multicentre, randomized, observer-blinded, controlled trial (CBTlate) (2019) (9)
- [Report from an ongoing research project: The Cologne Research and Development Network (CoRe-Net) and the value-based approach to healthcare]. (2018) (9)
- Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer’s Disease Spectrum: Association with Amyloid Pathology and Diagnostic Usefulness (2019) (9)
- Quality of health care with regard to detection and treatment of mental disorders in patients with coronary heart disease (MenDis-CHD): study protocol (2019) (9)
- Layer Cross-Fading at Organic/Organic Interfaces in OVPD-Processed Red Phosphorescent Organic Light Emitting Diodes as a New Concept to Increase Current and Luminous Efficacy (2009) (9)
- Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer’s disease spectrum (2020) (9)
- Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysis. (2010) (8)
- FC2D COGNITIVE AND NEUROBIOLOGICAL RISK INDICATORS IN EARLY AND LATE PRODROMAL STAGES (2006) (8)
- Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer’s disease (2006) (8)
- Amyloid b peptide ratio 42 / 40 but not A b 42 correlates with phospho-Tau in patients with low-and high-CSF A b 40 load (2007) (8)
- Novelty-Related fMRI Responses of Precuneus and Medial Temporal Regions in Individuals at Risk for Alzheimer Disease (2022) (8)
- Prediction of dementia of Alzheimer type by different types of subjective cognitive decline (2020) (8)
- Contribution of Apolipoprotein E and Cathepsin D Genotypes to the Familial Aggregation of Alzheimer’s Disease (2004) (7)
- [Reliability of multicenter magnetic resonance imaging. Results of a phantom test and in vivo measurements by the German Dementia Competence Network]. (2006) (7)
- Treatment of hypersexuality in Parkinson's disease with carbamazepine—A case report (2009) (7)
- Framework : Toward a Biological Definition of Alzheimer ' s Disease (2018) (7)
- Amyloid pathology but not APOE ε4 status is permissive for tau-related hippocampal dysfunction (2022) (7)
- [Treating Late Life Depression with Antidepressants--A Summary of Recommendations in International Guidelines]. (2015) (7)
- Promoting stigma coping and empowerment in patients with schizophrenia and depression: results of a cluster-RCT (2019) (7)
- A GERMAN VERSION OF THE LIFETIME OF EXPERIENCES QUESTIONNAIRE (LEQ) TO MEASURE COGNITIVE RESERVE: VALIDATION RESULTS FROM THE DELCODE STUDY (2018) (7)
- PLASMA HOMOCYSTEINE AND CEREBROSPINAL FLUID NEURODEGENERATION BIOMARKERS IN MILD COGNITIVE IMPAIRMENT AND DEMENTIA (2009) (7)
- 18F-PI2620 TAU-PET IN PROGRESSIVE SUPRANUCLEAR PALSY: A MULTI-CENTER EVALUATION (2019) (6)
- Characterization of Cerebellar Atrophy and Resting State Functional Connectivity Patterns in Sporadic Adult-Onset Ataxia of Unknown Etiology (SAOA) (2019) (6)
- Resting-State Network Alterations Differ between Alzheimer's Disease Atrophy Subtypes. (2021) (6)
- 18F-PI2620 TAU-PET IN PROGRESSIVE SUPRANUCLEAR PALSY: A MULTI-CENTER EVALUATION (2019) (6)
- Refining the understanding of typical Alzheimer disease (2019) (6)
- ABNORMAL FUNCTIONAL CONNECTIVITY WITHIN DEFAULT MODE NETWORK IN PERSONS WITH SUBJECTIVE COGNITIVE DECLINE: SELF-REFLECTION OF OWN MEMORY DEFICITS? (2016) (6)
- Advance directives for future dementia can be modified by a brief video presentation on dementia care: An experimental study (2018) (6)
- What are we trying to prevent in Alzheimer disease? (2019) (6)
- Introduction of Innovative Dopant Concentration Profiles to Broaden the Recombination Zone of Phosphorescent OVPD-Processed Organic Light Emitting Diodes (2009) (6)
- Interaction of two genes possibly involved in the regulation of the amyloid precursor protein (APP) processing (2000) (6)
- [Prevention of cognitive decline and dementia by treatment of risk factors]. (2019) (6)
- [ICD-11: Neurocognitive Disorders]. (2018) (6)
- Not all, but specific types of cognitive complaints predict decline to MCI (2018) (6)
- General practitioners’ attitude toward early and pre‐dementia diagnosis of AD in five European countries—A MOPEAD project survey (2021) (6)
- No association of the variant rs11887120 in DNMT3A with cognitive decline in individuals with mild cognitive impairment. (2016) (5)
- Subjective cognitive decline in idiopathic Parkinson´s disease: A systematic review (2021) (5)
- Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network (2022) (5)
- Progression of Subjective Cognitive Decline to MCI or Dementia in Relation to Biomarkers for Alzheimer Disease (2022) (5)
- Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum. (2021) (5)
- Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive Decline (2021) (5)
- A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2 (2020) (5)
- Alzheimer’s Disease Plasma Biomarkers Distinguish Clinical Diagnostic Groups in Memory Clinic Patients (2022) (5)
- Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type. (2022) (5)
- A randomized, double-blind, placebo-controlled dose-finding trial of intravenous immunoglobulin (IVIG; Octagam® 10%, Octapharma AG) in patients with mild to moderate Alzheimer's disease (GAM10-04) (2011) (5)
- [Early detection of Alzheimer's disease and approaches for prevention]. (2019) (4)
- Feasibility of Digital Memory Assessments in an Unsupervised and Remote Study Setting (2022) (4)
- What are the risk factors for avoidable transitions in the last year of life? A qualitative exploration of professionals’ perspectives for improving care in Germany (2021) (4)
- Psychotherapeutic interventions in individuals at risk for Alzheimer’s dementia: a systematic review (2020) (4)
- Cognitive Complaints in Memory Clinic Patients and in Depressive Patients: An Interpretative Phenomenological Analysis (2019) (4)
- IMPAIRED VISUAL FEATURE BINDING IN PATIENTS AT RISK FOR ALZHEIMER'S DISEASE: EVIDENCE FROM PATIENTS WITH SUBJECTIVE COGNITIVE DECLINE (SCD) AND FROM PATIENTS WITH MCI (2014) (4)
- Si(111) as alternative substrate for AlGaN/GaN HEMT (2003) (4)
- MRI as a Surrogate Marker in Clinical Trials in Alzheimer’s Disease (2009) (4)
- Advanced buffers for AlGaN/GaN HEMT and InGaN/GaN MQW on silicon substrates (2006) (4)
- Anti-amyloid antibody therapies in Alzheimer's disease. (2023) (4)
- Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 (2021) (4)
- Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 (2021) (4)
- [Reliability of morbidity data reported by GPs. Results of a longitudinal study in primary care]. (2012) (4)
- CNS cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease (2011) (4)
- Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management Study (2022) (4)
- Cognitive, Genetic, Brain Volume, and Diffusion Tensor Imaging Markers as Early Indicators of Dementia (2020) (4)
- Health literacy in clinical‐high‐risk individuals for psychosis: A systematic mixed‐methods review (2019) (4)
- Distribution volume of the nicotinic acetylcholine receptor ligand 2-[F-18]F-A-85380: Nonsmokers versus smokers (2006) (4)
- [Evidence-based standards for care of patients with dementia. The interdisciplinary S3 guideline for dementia]. (2010) (3)
- ABNORMAL FUNCTIONAL CONNECTIVITY WITHIN DEFAULT MODE NETWORK IN PERSONS WITH SUBJECTIVE COGNITIVE DECLINE: SELF-REFLECTION OF OWN MEMORY DEFICITS? (2016) (3)
- LATENT-FACTOR STRUCTURE OF THE DELCODE STUDY NEUROPSYCHOLOGICAL TEST BATTERY (2017) (3)
- Targeting Lifestyle Behavior to Improve Brain Health: User-Experiences of an Online Program for Individuals with Subjective Cognitive Decline (2020) (3)
- [Therapy of psychological and behavioral symptoms in dementia]. (2010) (3)
- [Therapy for patients with dementia. Treatment strategies in the elderly]. (2014) (3)
- Protective association of HLA‐DRB1*04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences (2022) (3)
- Identification of undiagnosed dementia cases using a web‐based pre‐screening tool: The MOPEAD project (2021) (3)
- EXPLAINABLE CONVOLUTIONAL NETWORKS AND MULTIMODAL IMAGING DATA: THE NEXT STEP TOWARDS USING ARTIFICIAL INTELLIGENCE AS DIAGNOSTIC TOOL FOR EARLY DETECTION OF ALZHEIMER'S DISEASE (2019) (3)
- Lifelong experiences as a proxy of cognitive reserve moderate the association between connectivity and cognition in Alzheimer's disease (2022) (3)
- A Remote Digital Memory Composite to Detect Cognitive Impairment in Memory Clinic Samples in Unsupervised Settings using Mobile Devices (2021) (3)
- Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects. Study Protocol of the PreDADQoL Project. (2021) (3)
- Association of a CAMK2A genetic variant with logical memory performance and hippocampal volume in the elderly (2020) (3)
- [Early detection of Alzheimer's disease and dementia prediction in patients with mild cognitive impairment : Summary of current recommendations]. (2020) (3)
- Detection and treatment of mental disorders in patients with coronary heart disease (MenDis-CHD): A cross-sectional study (2020) (3)
- [Cognitive Behavioral Therapy and Assertive Community Treatment Reduces Days in Hospital and Delays Hospital Admission in Severe Psychotic Disorders]. (2016) (3)
- [Guideline-adherent inpatient psychiatric psychotherapeutic treatment of behavioral and psychological symptoms of dementia : Normative definition of personnel requirements]. (2017) (3)
- Subjective memory impairment in healthy elderly specifically predicts decline in episodic memory over 8 years (2013) (3)
- Influence of Substrate Temperature on Multilayer Thin Film Growth, Charge Carrier Injection and Efficiency of OVPD-processed Organic Light Emitting Diodes (2008) (3)
- Analysis of Psychological Symptoms Following Disclosure of Amyloid–Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline (2023) (3)
- The Clinical Use of Alzheimer’s Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer’s Disease Consortium Survey (2022) (3)
- Cholinergic white matter pathways along the Alzheimer's disease continuum (2022) (3)
- The role of the right inferior parietal lobule in the calculation of saccade amplitude: An fMRI study (2001) (2)
- PROSPECTIVE ASSOCIATIONS BETWEEN VITAMINS, METABOLITES, AND OVERALL DEMENTIA IN THE OLDEST-OLD (2017) (2)
- A conceptual framework of subjective cognitive decline (SCD) in preclinical Alzheimer's disease (AD) (2013) (2)
- [Clinical Phenomenology of Autoimmune Encephalitis]. (2016) (2)
- Cross-Cultural Longitudinal Study on Cognitive Decline (CLoCODE) for Subjective Cognitive Decline in China and Germany: A Protocol for Study Design. (2022) (2)
- Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer's Disease. (2022) (2)
- Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study (2015) (2)
- Neural correlates and predictors of subjective cognitive decline in patients with Parkinson’s disease (2021) (2)
- European consensus for the diagnosis of MCI and mild dementia: Preparatory phase. (2022) (2)
- Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial (2022) (2)
- [Advance directive of probands in pharmaceutical research : A medical ethics discussion]. (2018) (2)
- Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults (2022) (2)
- [Novel neuroimaging perspectives in the diagnosis of dementia]. (2008) (2)
- Depression im Alter – Diagnostik, Pathophysiologie und therapeutische Strategien (2018) (2)
- One step towards dementia prevention (2018) (2)
- EXPECTATIONS OF PATIENTS WITH MCI AND THEIR CAREGIVERS TOWARD PREDICTIVE DIAGNOSIS OF AD: A QUALITATIVE APPROACH (2017) (2)
- Functional characterization of a novel TREM2 coding variant linked to familial Alzheimer’s disease (2015) (2)
- Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk. (2015) (2)
- Complementary pre‐screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project (2021) (2)
- WHAT IS MEMORABLE IS CONSERVED ACROSS HEALTHY AGING, EARLY ALZHEIMER’S DISEASE, AND NEURAL NETWORKS (2017) (2)
- Rare Variant Testing of Imputed Data: An Analysis Pipeline Typified (2014) (2)
- Correction: Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease (2011) (2)
- Cognitive reserve moderates the functional connectivity changes in resting-state (2021) (2)
- A One-Degree-of-Freedom Test for Supra-Multiplicativity of SNP Effects (2013) (2)
- CSF beta-amyloid 42, CSF tau, hippocampal volume and verbal episodic memory performance in early versus late mild cognitive impairment (2013) (1)
- Decreased cortical thickness in individuals with subjective cognitive decline with and without CSF‐AD‐pathology: Data from the DELCODE Study (2020) (1)
- Impaired self-awareness of cognitive deficits in Parkinson's disease relates to cingulate cortex dysfunction (2021) (1)
- USEFULNESS AND STABILITY OF MULTICENTER DIFFUSION TENSOR IMAGING AS AN EARLY MARKER FOR SUBJECTIVE COGNITIVE DECLINE AND AMNESTIC MILD COGNITIVE IMPAIRMENT: FIRST RESULTS FROM THE PROSPECTIVE DZNE DELCODE STUDY (2017) (1)
- DISENTANGLING THE TEMPORAL SEQUENCE OF SUBJECTIVE COGNITIVE DECLINE, DEPRESSIVE SYMPTOMS AND MEMORY DETERIORATION: A TRIVARIATE LATENT DIFFERENCE SCORE ANALYSIS (2019) (1)
- Plasma 24S-hydroxycholesterol (cerebrosterol): An indicator of neuronal degeneration and potential state marker for dementia (2000) (1)
- The effect of a mindfulness‐based versus health self‐management intervention on cognitive performance in older adults with subjective cognitive decline (SCD): The SCD‐Well randomized controlled trial (2021) (1)
- Convergent abnormalities of β-amyloid deposition, glucose metabolism, and fMRI activity in the dorsal precuneus in subjective cognitive decline (2021) (1)
- Basal forebrain atrophy along the Alzheimer’s disease spectrum and its relevance for subjective cognitive decline (2020) (1)
- Low Serum Vitamin D Status Is Associated with Incident Alzheimer’s Dementia in the Oldest Old (2022) (1)
- LEVELS OF THE ASTROCYTE-DERIVED PROTEINS GFAP AND S100B IN THE CEREBROSPINAL FLUID OF HEALTHY INDIVIDUALS AND ALZHEIMER’S DISEASE PATIENTS AT DIFFERENT DISEASE STAGES (2018) (1)
- SUBJECTIVE COGNITIVE DECLINE AND PROGRESSION TO DEMENTIA DUE TO AD AND NON-AD IN MEMORY CLINIC AND COMMUNITY-BASED COHORTS (2016) (1)
- Harmonisation and Between-Country Differences of the Lifetime of Experiences Questionnaire in Older Adults (2021) (1)
- Attention in subjective cognitive decline – Authors' reply (2020) (1)
- Histologically confirmed amyloid deposition and low CSF Aβ42 in a cognitively normal subject (2007) (1)
- Lifelong music practice as reserve factor: Associations with cognition and brain structure in older adults (2021) (1)
- Evidence for neuronal compensation during episodic memory in subjective memory impairment (2011) (1)
- PET-Imaging of a4ß2* nicotinic acetylcholine receptors in the central and peripheral nervous system (2006) (1)
- Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments (2021) (1)
- [Memory Clinics in Germany - Results of a Hospital Survey]. (2019) (1)
- Musical Activity During Life Is Associated With Multi-Domain Cognitive and Brain Benefits in Older Adults (2022) (1)
- Polymorphism in ABCA 1 influences CSF 24 S-hydroxycholesterol levels but is not a major risk factor of Alzheimer ' s disease (1)
- An application of electronic nose technology for diagnosis of Alzheimer's disease (2013) (1)
- LOCAL AND GLOBAL RESTING STATE ALTERATIONS IN DIFFERENT STAGES DURING THE DEVELOPMENT OF ALZHEIMER’S DISEASE AS DEMONSTRATED IN THE DZNE DELCODE COHORT (2017) (1)
- [Memory clinics in Germany-structural requirements and areas of responsibility]. (2020) (1)
- Memorability analysis for diagnostic photographs in cognitive assessment: Linking behavioral performance with biomarker status (2021) (1)
- Identification of a Cascade of Changes in Activities of Daily Living Preceding Short-Term Clinical Deterioration in Mild Alzheimer’s Disease Dementia via Lead-Lag Analysis (2020) (1)
- A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer’s Disease: Results from the MOPEAD Project (2021) (1)
- Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia (2017) (1)
- IMPACT OF NON-PHARMACOLOGIC INTERVENTIONS ON COGNITIVE, BEHAVIORAL, AND EMOTIONAL FUNCTIONING IN OLDER ADULTS WITH SUBJECTIVE COGNITIVE DECLINE: A SYSTEMATIC REVIEW OF CONTROLLED TRIALS (2016) (1)
- [The importance of molecular imaging (PET) in the diagnostics of dementia]. (2018) (1)
- T40. Alzheimer’s Disease DNA (Hydroxy)Methylome in the Brain and Blood: Evidence for OXT Methylation as a Preclinical Marker (2019) (1)
- The IMI‐EU H2020 project MOPEAD: Outcome of different screening methods to identify MCI/early AD (2020) (1)
- [Comment on the S3 guidelines Dementia by the DGPPN and the DGN from the psychiatric point of view]. (2010) (1)
- CCL17-deficiency alters myeloid cell-responses and prevents cognitive decline in APP/PS1-mice (2015) (1)
- Arterial Spin Labeling in Dementia (2010) (1)
- Feasibility of mobile app‐based assessment of memory functions: Insights from a citizen science study (2020) (1)
- STRUCTURAL INTEGRITY IN SUBJECTIVE COGNITIVE DECLINE, MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE BASED ON MULTICENTER DIFFUSION TENSOR IMAGING: RESULTS FROM THE DELCODE STUDY (2018) (1)
- Social Cognition in Patients with Amnestic Mild Cognitive Impairment and Mild Dementia of the Alzheimer Type. (2021) (1)
- Performance evaluation of automated white matter hyperintensity segmentation algorithms in a multicenter cohort on cognitive impairment and dementia (2023) (1)
- Performance of different research criteria and cognitive tests to predict incident Alzheimer’s disease (2013) (1)
- MR-Spectroscopy in Dementia (2010) (1)
- Measurement and Modeling of Hole Transport in Blends of N,N'-diphenyl-N,N'-bis(1-naphthyl)-1,1'-biphenyl-4,4'-diamine (NPB) and the Hole-conducting Material HIM (2008) (1)
- Subjective cognitive decline and subsequent dementia: a nationwide cohort study of 579,710 people aged 66 years in South Korea (2020) (1)
- [Pharmacological prevention of cognitive decline and dementia]. (2020) (1)
- Amyloid-related changes of basal forebrain volume and precuneus functional connectivity in Subjective Cognitive Decline patients (2020) (1)
- Big Five, self-reported depression, and anxiety are predictive for Alzheimer's disease (2022) (1)
- Quantitative amyloid PET in the AMYPAD diagnostic and patient management study (2021) (1)
- The Promotion of Health Literacy (2023) (1)
- Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort (2022) (1)
- A Comparison of Operational Definitions for Mild Cognitive Impairment (2022) (1)
- Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia. (2022) (1)
- Dementia prevention in memory clinics: recommendations from the European task force for brain health services (2023) (1)
- Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study (2023) (1)
- Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 (2021) (1)
- Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 (2021) (1)
- Demands on Health Information and Clinical Practice Guidelines for Patients from the Perspective of Adults with Mental Illness and Family Members: A Qualitative Study with In-Depth Interviews (2022) (1)
- Brain Functional Alterations and Association with Cognition in People with Preclinical Subjective Cognitive Decline and Objective Subtle Cognitive Difficulties (2023) (1)
- What Matters to Patients with Alzheimer’s Disease and Their Care Partners? Implications for Understanding the Value of Future Interventions (2022) (1)
- The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact (2023) (1)
- Combination Therapy for Alzheimer’s Disease — The Next Step (2019) (1)
- Structural and Functional Magnetic Resonance Imaging: Mild Cognitive Impairment and Alzheimer Disease. (2013) (1)
- [Mild neurocognitive disorder - a disease? For]. (2014) (1)
- P3-075 Hippocampal volume reduction in elderly individuals with subjective memory impairment (2004) (1)
- Linking early-life bilingualism and cognitive advantage in older adulthood (2022) (0)
- THE ASSOCIATION OF AD PATHOLOGY WITH NEUROPSYCHIATRIC SYMPTOMS AND WORRY IN SUBJECTIVE COGNITIVE DECLINE - DATA FROM THE DELCODE STUDY (2019) (0)
- Apathy in patients with Alzheimer's disease is a cost-driving factor. (2023) (0)
- ANOSOGNOSIA AND CSF-BIOMARKERS IN NONDEMENTED OLDER ADULTS: RESULTS FROM THE DELCODE-STUDY (2019) (0)
- EP 17. Preserved frontoparietal brain morphology correlates with beneficial response to deep brain stimulation of the Nucleus basalis of Meynert in patients with Alzheimer’s disease (2016) (0)
- OBJECT AND SCENE MEMORY ARE DIFFERENTIALLY ASSOCIATED WITH CSF MARKERS OF ALZHEIMER’S DISEASE AND MRI VOLUMETRY (2017) (0)
- Contents of volume 253 (2003) (2003) (0)
- Proton MR spectroscopy of the hippocampus at 3 Tesla in patients with major depression under pharmacological treatment (2008) (0)
- Homocysteine metabolism and CSF markers for Alzheimer's disease (2009) (0)
- OCCUPATIONAL COGNITIVE REQUIREMENTS ARE AN IMPORTANT PROXY MEASURE OF COGNITIVE RESERVE: EVIDENCE FROM THE AGECODE AND DELCODE STUDIES (2018) (0)
- Steps towards the implementation of amyloid‐PET in memory clinics: AMYPAD Diagnostic and Patient Management Study (2022) (0)
- FC02.05 Association of a cathepsin D gene polymorphism with Alzheimer's disease (2000) (0)
- ASSOCIATION BETWEEN NEURAL NOVELTY RESPONSES AND CSF BIOMARKERS OF ALZHEIMER’S DISEASE: ANATOMICAL SPECIFICITY AND DEPENDENCE ON ATROPHY (2018) (0)
- Individualized MR‐based prediction of cognitive performance in subjects at risk of dementia (2021) (0)
- MODELING OF HIDDEN CAUSES FOR DYNAMIC CHANGES IN STRUCTURAL INTEGRITY AND COGNITION IN SUBJECTIVE COGNITIVE DECLINE: A DELCODE PROJECT (2017) (0)
- Gender differences in the perception of subjective vs. objective cognitive decline: Baseline data from the SCD‐Well Trial (2020) (0)
- APOE-ε4 MODULATES LEVELS OF OMEGA-3 AND OMEGA-6 FATTY ACIDS IN ALZHEIMER’S DISEASE DEMENTIA (2018) (0)
- P1-252: A multicenter 1H-MRS study of the medial temporal lobe in Alzheimer's disease and mild cognitive impairment (2008) (0)
- Exploring the ATN classification system using brain morphology (2021) (0)
- Cerebral perfusion changes in untreated schizophrenic patients: A CASL-study at 3 Tesla (2006) (0)
- Year : 2011 A genome-wide survey of human short-term memory (2010) (0)
- Tau plasma levels in subjective cognitive decline: Results from the DELCODE study (2017) (0)
- PATTERNS OF INCREASED AND DECREASED PRECUNEUS FUNCTIONAL CONNECTIVITY IN SCD DEPENDING ON AMYLOID STATUS (2019) (0)
- Subjective cognitive decline and subsequent dementia: a nationwide cohort study of 579,710 people (66 year-olds) in South Korea (2019) (0)
- Predictors of preclinical Alzheimer’s disease in persons with subjective cognitive decline (2020) (0)
- Awareness of cognitive decline and CSF‐biomarkers in memory clinic patients: Results from the DELCODE‐study (2020) (0)
- Difference in Amyloid Load Between Single Memory Domain and Multidomain Subjective Cognitive Decline: A Study from the SILCODE. (2021) (0)
- Pre‐screening models for patient engagement: The MOPEAD project (2020) (0)
- SUBJECTIVE COGNITIVE DECLINE IS ASSOCIATED WITH CSF AMYLOID B 1-42, DEPRESSIVE SYMPTOMS AND EPISODIC MEMORY PERFORMANCE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT (2014) (0)
- LEVEL OF BRAIN RESERVE ASSOCIATED WITH SPATIAL EXTENT OF TAU-NEURODEGENERATION PATTERN IN ALZHEIMER’S DISEASE (2018) (0)
- FDG-PET and Structural MRI in Subjective Memory Impairment (2009) (0)
- EVIDENCE FOR AMYLOID PATHOLOGY IN SCD-DATA FROM THE DELCODE STUDY (2017) (0)
- P02.255 The relationship between alzheimer's disease, early onset and late-onset depression in the elderly assessed in a family study (2000) (0)
- Regional 1H-MR-spectroscopy with respect to the theoretical distribution of neuropathology in AD patients (2000) (0)
- INTERPRETATIVE PHENOMENOLOGICAL ANALYSIS OF COGNITIVE COMPLAINTS REVEALS COMMONALITIES AND DIFFERENCES BETWEEN MEMORY-CLINIC PATIENTS, DEPRESSIVE PATIENTS, AND HEALTHY ELDERLY (2017) (0)
- Association of acetylcholinesterase inhibitor and memantine treatment with cognitive function in patients with clinical dementia syndrome with and without post‐mortem Alzheimer pathology (2022) (0)
- Evaluation of the efficacy and safety of orally administered BI425809 during a 12‐week treatment period compared with placebo in patients with cognitive impairment due to Alzheimer’s disease (2020) (0)
- The use of amyloid‐PET in memory clinic patients: AMYPAD Diagnostic and Patient Management Study (2022) (0)
- Cognitive Behavioral Therapy for Late-Life Depression (CBTlate): Results of a Multicenter, Randomized, Observer-Blinded, Controlled Trial. (2023) (0)
- Power values a of SMT under 3-SNP-recessive models. (2013) (0)
- Hippocampal volumetric variability is associated with memory in subjective cognitive decline (2020) (0)
- The relationship of CSF biomarker of tau to in vivo tau pathology is mediated by amyloid levels in AD patients (2017) (0)
- SUBJECTIVE COGNITIVE DECLINE VERSUS SUBTLE DEFICITS AS INDICATORS OF PRECLINICAL AD: RESULTS FROM THE MULTICENTER OBSERVATIONAL STUDY ON PREDEMENTIA ALZHEIMER’S DISEASE (DELCODE) STUDY (2019) (0)
- A cost‐consequence analysis of early detection of AD in the MOPEAD project — A project within the EU research agenda IMI‐2 (2020) (0)
- COUNSELING AND DISCLOSURE IN RISK PREDICTION OF ALZHEIMER’S DEMENTIA: IMPACT ON MCI PATIENTS AND THEIR CAREGIVERS—THE PREDADQOL STUDY (2018) (0)
- THE SCD-WELL RANDOMIZED CONTROLLED TRIAL: EFFECTS OF A MINDFULNESS-BASED INTERVENTION VERSUS HEALTH EDUCATION ON MENTAL HEALTH AND COGNITION IN PATIENTS WITH SUBJECTIVE COGNITIVE DECLINE (2019) (0)
- ALTERATIONS OF INTRINSIC CONNECTIVITY IN POSTERIOR DEFAULT MODE NETWORK ACROSS AT RISK STAGES OF ALZHEIMER’S DEMENTIA (2019) (0)
- CORTICAL AMYLOID BURDEN CORRELATES WITH ATROPHY OF THE POSTERIOR PART OF THE NUCLEUS BASALIS MEYNERT IN AMYLOID-POSITIVE SCD (2019) (0)
- The psychological consequences of living with coronary heart disease: Are patients' psychological needs served? A mixed‐method study in Germany (2022) (0)
- Effect of Neuroinflammation on white matter structure and memory performance in the spectrum from aging to AD (2022) (0)
- Investigating brain structure in different FTLD subtypes using voxel-based morphometry – Data from the multicentric FTLD consortium’s study Germany (2014) (0)
- EICOSAPENTAENOIC ACID BUT NOT DOCOSAHEXAENOIC ACID IS ASSOCIATED WITH ALZHEIMER’S DISEASE RISK IN THE OLDEST-OLD (2018) (0)
- THE AMYPAD-DX CONTROLLED TRIAL ON THE DIAGNOSTIC VALUE OF AMYLOID PET (2017) (0)
- A Cognitive Reserve Network That Moderates the Relationship Between Alzheimer’s Disease Pathology and Cognition (2022) (0)
- Using neuropsychological criteria to distinguish between memory clinic patients with subjective cognitive decline and MCI (2015) (0)
- OPTIMAL HARMONIZATION OF COGNITIVE MEASURES ENHANCES THE DETECTION OF GENETIC EFFECTS ON ALZHEIMER’S DISEASE PROGRESSION: A COMPARISON OF SIX STATISTICAL APPROACHES IN 1796 MCI PATIENTS FROM THREE COHORTS (2017) (0)
- Compounds in exhaled air for the detection of Alzheimer's disease (2013) (0)
- CONNECTIVITY OF THE LEFT FRONTAL CORTEX ATTENUATES DETRIMENTAL EFFECTS OF CSF-TAU ON MEMORY IN PRECLINICAL AND CLINICAL ALZHEIMER’S DISEASE (2017) (0)
- RELATIONSHIP BETWEEN LOCAL RESTING STATE ACTIVITY, β-AMYLOID DEPOSITION AND MEMORY PERFORMANCE IN THE DZNE: LONGITUDINAL COGNITIVE IMPAIRMENT AND DEMENTIA STUDY (DELCODE) (2018) (0)
- MODELS OF PATIENT ENGAGEMENT IN ALZHEIMER’S DISEASE (MOPEAD): A EUROPEAN MULTINATIONAL PROJECT TO DEVELOP AND TEST INNOVATIVE PATIENT ENGAGEMENT STRATEGIES (2018) (0)
- Neural mechanisms of subjective memory impairment (2009) (0)
- Comparison of Patient and Proxy Assessment of Patient-Centeredness in the Care of Coronary Heart Disease: A Cross Sectional Survey Using the PACIC-S11.1 (2020) (0)
- In vivo amyloid staging in individuals with subjective cognitive decline in DELCODE Study (2021) (0)
- CORTICAL AMYLOID BURDEN CORRELATES WITH ATROPHY OF THE POSTERIOR PART OF THE NUCLEUS BASALIS MEYNERT IN AMYLOID-POSITIVE SCD (2019) (0)
- PREVALENCE OF PRECLINICAL ALZHEIMER’S DISEASE IN PATIENTS WITH SUBJECTIVE COGNITIVE DECLINE: COMPARISON OF THREE EUROPEAN MEMORY CLINIC SAMPLES (2016) (0)
- Interindividual variability of cerebral activation in a verbal memory paradigm (2000) (0)
- Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve (2022) (0)
- Algorithmic Fairness in Biomarker‐Based Machine Learning Models to Predict Alzheimer’s Dementia in Individuals with Mild Cognitive Impairment (2022) (0)
- Frontal activation is related to retrieval effort in a continuous recognition paradigm (2000) (0)
- F167. ACCESS, UNDERSTAND, APPRAISE AND APPLY TO / OF HEALTH INFORMATION AND HEALTH LITERACY IN INDIVIDUALS AT-RISK FOR PSYCHOSIS: A SYSTEMATIC REVIEW (2018) (0)
- Distribution volume of the nicotinic acetylcholine receptor ligand 2-[F-18]F-A-85380 studied in smokers and non-smokers (2006) (0)
- APPLICATION OF THE ‘A/T/N’ BIOMARKER CLASSIFICATION SYSTEM IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT: CONVERSION RATES TO AD AND OTHER DEMENTIAS (2017) (0)
- A residual marker of cognitive reserve is associated with resting-state intrinsic functional connectivity along the Alzheimer's disease continuum (2022) (0)
- IN VIVO TAUOPATHY MEASURED WITH [18F]-AV-1451 IS DIFFERENTIALLY RELATED TO CSF BIOMARKERS OF TAU IN ALZHEIMER’S DISEASE: THE INFLUENCE OF AMYLOID DEPOSITION (2017) (0)
- Prediction of Alzheimer dementia – current state (2013) (0)
- THE PHENOMENOLOGY AND THE NEURONAL CORRELATES OF EPISODIC FUTURE IMAGINATION IN PERSONS WITH SUBJECTIVE COGNITIVE DECLINE AND HEALTHY CONTROLS (2017) (0)
- USING NEUROMELANIN-SENSITIVE MRI TO CHARACTERISE THE STRUCTURAL INTEGRITY OF THE HUMAN LOCUS COERULEUS AT DIFFERENT STAGES OF ALZHEIMER’S DISEASE (2017) (0)
- Support vector machine classification enables detection of primary progressive aphasia subtypes with MRI (2015) (0)
- Subjective memory impairment – A 18F-FDG PET cross-sectional case-control study (2006) (0)
- Personalized risk for clinical progression in cognitively normal subjects—the ABIDE project (2019) (0)
- The last year of life for patients dying from cancer vs. non-cancer causes: a retrospective cross-sectional survey of bereaved relatives (2022) (0)
- QUALITY ASSURANCE IN DELCODE: A MULTI-CENTER NEUROIMAGING STUDY (2017) (0)
- Papassotiropoulos 2010 MolPsychiat Supplementary (2014) (0)
- Smoking upregulates a4ß2* nicotinic acetylcholine receptors in brainstem and cerebellum (2006) (0)
- Baseline features of the AMYPAD Diagnostic and Patient Management Study (DPMS) participants (2020) (0)
- Novel genetic matching methods for handling population stratification in genome-wide association studies (2015) (0)
- RISK KNOWLEDGE OF MCI PATIENTS IN PREDICTIVE DIAGNOSIS OF ALZHEIMER’S DEMENTIA: PRELIMINARY DATA OF A MIXED METHOD APPROACH—THE PREDADQOL STUDY (2018) (0)
- Neuroanatomical correlates of the behavioral and psychiatric symptoms in Alzheimer's disease: A voxel-based morphometry study (2013) (0)
- ASSESSMENT OF SOCIAL COGNITIVE ABILITIES IN PATIENTS WITH MCI AND MILD AD COMPARED TO YOUNGER AND OLDER HEALTHY CONTROLS (2018) (0)
- Smoking upregulates α4ß2* nicotinic acetylcholine receptors in brainstem and cerebellum (2006) (0)
- Individualized Gaussian Process-based Prediction of Memory Performance and Biomarker Status in Ageing and Alzheimer’s disease (2022) (0)
- HIPPOCAMPAL GREY MATTER ATROPHY IS ASSOCIATED WITH THE FREE AND CUED SELECTIVE REMINDING TEST (2014) (0)
- The clinical use of Alzheimer’s biomarkers in patients with mild cognitive impairment (2021) (0)
- P3-001 Alterations of peripheral cholesterol metabolites, 24S- and 27-hydroxycholesterol in demented patients (2004) (0)
- Prediction of amyloid‐positivity in individuals with subjective cognitive decline: Machine learning approaches to optimize number‐needed‐to‐screen (2021) (0)
- CONNECTIVITY OF THE LEFT FRONTAL CORTEX ATTENUATES DETRIMENTAL EFFECTS OF CSF-TAU ON MEMORY IN PRECLINICAL AND CLINICAL ALZHEIMER’S DISEASE (2017) (0)
- IC-P-038 FDG PET in subjective memory impairment (2006) (0)
- Neuroanatomical correlates of the behavioral and psychiatric symptoms in Alzheimer's disease: A voxel-based morphometry study (2013) (0)
- Plasma biomarkers distinguish clinical diagnostic groups in memory clinic patients (2021) (0)
- ALTERATIONS OF INTRINSIC CONNECTIVITY IN POSTERIOR DEFAULT MODE NETWORK ACROSS AT RISK STAGES OF ALZHEIMER’S DEMENTIA (2019) (0)
- MICROSTRUCTURAL CHANGES IN ALZHEIMER’S DISEASE, MILD COGNITIVE IMPAIRMENT, AND SUBJECTIVE COGNITIVE DECLINE BASED ON MULTICENTER DIFFUSION TENSOR IMAGING: A TBSS ANALYSIS OF DELCODE DATA (2018) (0)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
- Detection of Neural Compensation at the Pre-Dementia State (2010) (0)
- DELAY DISCOUNTING IN SUBJECTS WITH SUBJECTIVE COGNITIVE DECLINE, ELDERLY CONTROLS, AND YOUNG CONTROLS (2014) (0)
- TBK1 loss-of function and dominant-negative mutations in an extended European cohort of FTD and ALS patients (2016) (0)
- Subject Index Vol. 7, 2010 (2010) (0)
- Association of domain‐specific cognitive functions with regional pattern of atrophy and functional connectivity across the Alzheimer’s disease spectrum: An analysis from the DELCODE cohort (2020) (0)
- Front & Back Matter (2012) (0)
- P2-153: Alterations of brain cholesterol metabolism: Relevance of desmosterol in Alzheimer’s disease and vascular dementia (2006) (0)
- Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 (2021) (0)
- SUBJECTIVE AND VERY FIRST OBJECTIVE COGNITIVE DECLINE (2018) (0)
- AMYPAD-DPMS PRELIMINARY RESULTS: PARTICIPANTS’ BASELINE FEATURES (2019) (0)
- Correlation of CSF biomarkers with 1H-MRS metabolites of the medial temporal lobe in Alzheimer's Disease (2009) (0)
- P3-122 APOE-ε4 MODULATES LEVELS OF OMEGA-3 AND OMEGA-6 FATTYACIDS IN ALZHEIMER’S DISEASE DEMENTIA (2018) (0)
- EFFECTS OF AGE AND CSF MEASURES OF TAU ON MNEMONIC DISCRIMINATION OF OBJECTS AND SCENES IN MEDIAL TEMPORAL LOBE PATHWAYS (2018) (0)
- Featured Article Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease (2014) (0)
- FUNCTIONAL CHARACTERIZATION OF A RARE GENETIC VARIANT IN PHOSPHOLIPASE Cγ2 WHICH IS ASSOCIATED WITH A BENEFICIAL EFFECT ON THE PROGRESSION OF ALZHEIMER’S DISEASE (2017) (0)
- First results of the AMYPAD Prognostic and Natural History Study: amyloid‐PET Centiloid predicts cognitive functioning in a pre‐dementia population (2022) (0)
- Estimating prevalence of subjective cognitive decline in and across international cohort studies of aging: a COSMIC study (2020) (0)
- SOCIAL COGNITION IN PATIENTS WITH MCI AND MILD AD (2019) (0)
- P4‐272: Withdrawn (2015) (0)
- Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2023) (0)
- "MOVE ON UP": THE MOBI ASSIST-PROGRAMME (2018) (0)
- Cortical thinning in subjective memory impairment (2013) (0)
- TREM2 is not associated with accelerated decline of the mini mental status examination in late onset Alzheimer's disease (2015) (0)
- Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease (2018) (0)
- Brain glucose metabolism in patients with mild to moderate Alzheimer's disease before and after six months treatment with intravenous immunoglobulin (octagam 10%): A phase II double blind, placebo-controlled multi-center study (2011) (0)
- INSPIRATION: Study design and preliminary results of a crosssectional risk AD‐profiling study (2021) (0)
- 6 .Diagnostische Methoden (2018) (0)
- Featured Research Sessions: F5-01: Subjective Cognitive Decline in Preclinical Alzheimer’s Disease P824 FEATURED RESEARCH SESSIONS: F5-01: SUBJECTIVE COGNITIVE DECLINE IN PRECLINICAL ALZHEIMER’S DISEASE F5-01-01 A CONCEPTUAL FRAMEWORK OF SUBJECTIVE COGNITIVE DECLINE (SCD) IN PRECLINICAL ALZHEIMER’S (2013) (0)
- Cortical thinning in subjective memory impairment (2013) (0)
- Lifestyle differences modulate the effects of cognitive reserve on functional connectivity (2020) (0)
- Neuroimaging in Dementia (2011) (0)
- Prognostic value of plasma Amyloid‐β 42/40 ratio in early and pre‐clinical AD (2022) (0)
- In vivo locus coeruleus imaging in Alzheimer’s and Parkinson’s disease (2020) (0)
- A four-center study on the effect of polygenic risk score on cerebrospinal fluid markers and memory decline in mild cognitive impairment patients (2015) (0)
- Reduced delay discounting through episodic future imagination in healthy old subjects but not in subjects with subjective cognitive decline: An fMRI study (2015) (0)
- CSF biomarkers and disease progression in an interrupted MCI trial (2012) (0)
- RELATIONSHIP BETWEEN GLOBAL CONNECTIVITY, AMYLOID AND TAU IN DIFFERENT STAGES DURING THE DEVELOPMENT OF ALZHEIMER’S DISEASE AS DEMONSTRATED IN THE DZNE DELCODE COHORT (2019) (0)
- Contents Vol. 78, 2014 (2015) (0)
- The effects of Mediterranean diet on memory and Alzheimer's disease biomarkers (2020) (0)
- Anosognosia in Alzheimer’s disease associated with tau accumulation and hypometabolism in frontal areas (2020) (0)
- RARE VARIANTS IN PLCG2, ABI3, AND TREM2 GENES ARE ASSOCIATED WITH ALZHEIMER’S DISEASE IN AN ARGENTINIAN SAMPLE: IS IT A EUROPEAN HERITAGE? (2018) (0)
- Genome-wide association study using cerebrospinal fluid biomarkers beta-amyloid-42 and pTau181 in German samples of Alzheimer's disease (2012) (0)
- 1H-MRS IN SUBJECTS WITH SCD, MCI AND AD (2016) (0)
- ROBUST AUTOMATED DETECTION OF SUBJECTIVE COGNITIVE DECLINE AND PRODROMAL ALZHEIMER’S DISEASE BASED ON MULTICENTER RESTING-STATE FUNCTIONAL CONNECTIVITY: RESULTS FROM THE DZNE DELCODE STUDY (2017) (0)
- Activation of Anterior Cingulate Gyrus, Right Medial Frontal Gyrus, and Parietal Visual Association Cortex during Retrieval: An Event-related Functional MRI-Analysis (1998) (0)
- Cerebrospinal fluid L-arginine and symmetrical dimethylarginine are associated with increased soluble amyloid precursor protein beta production in Alzheimer's disease (2012) (0)
- Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study (2019) (0)
- P2-283 FDG-PET in subjective memory impairment (2006) (0)
- Classifying primary progressive aphasias individually with support vector machine approaches in MRI data (2016) (0)
- IC-P-155 STRUCTURAL INTEGRITY IN SUBJECTIVE COGNITIVE DECLINE, MILD COGNITIVE IMPAIRMENTAND ALZHEIMER’S DISEASE BASED ON MULTICENTER DIFFUSION TENSOR IMAGING: RESULTS FROMTHEDELCODE STUDY (2018) (0)
- Association between SCD‐Plus features and GDS factors in subjective cognitive decline and healthy controls in the studies DELCODE and SILCODE (2021) (0)
- Impact of the disclosure of amyloid‐PET results to patients with subjective cognitive decline: the AMYPAD Diagnostic and Patient Management Study (DPMS) (2020) (0)
- IC-P-066 A multicenter 1H-MRS study of the medial temporal lobe in MCI and dementia (2006) (0)
- Substantia nigra integrity is associated with poorer recognition memory for novel stimuli in early Alzheimer’s disease (2022) (0)
- First results of the AMYPAD Prognostic and Natural History Study: amyloid‐PET centiloids predicts cognitive functioning in a pre‐dementia population (2022) (0)
- Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to AD among subjects with mild cognitive impairment (2016) (0)
- THE PHENOMENOLOGY AND THE NEURONAL CORRELATES OF EPISODIC FUTURE IMAGINATION IN PERSONS WITH SUBJECTIVE COGNITIVE DECLINE AND HEALTHY CONTROLS (2017) (0)
- CORTICAL THINNING IN SUBJECTIVE COGNITIVE DECLINE WITH AND WITHOUT AD PATHOLOGY: DATA FROM THE DELCODE STUDY (2018) (0)
- A high fMRI activation deviation score is linked to worse clinical phenotype and Aß42/40 positivity. (2020) (0)
- STATUS QUO OF HEALTH LITERACY IN INDIVIDUALS AT RISK FOR DEVELOPING ALZHEIMER'S DISEASE: FIRST DATA OF A SYSTEMATIC REVIEW (2018) (0)
- Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples (2019) (0)
- Cost of illness of apathy in Alzheimer’s disease (2021) (0)
- [Brain health services: individual dementia risk profiling at the Cologne Alzheimer Prevention Center]. (2023) (0)
- Editorial: Exploring Reliable Markers and Prediction Indexes for the Progression From Subjective Cognitive Decline to Cognitive Impairment (2021) (0)
- Early-Phase F-18-PI-2620 Tau-PET Imaging as a Surrogate Marker of Neurodegeneration (2019) (0)
- Randomized double-blind placebo-controlled dose-finding trial of intravenous immunoglobulin (octagam® 10%, octapharma AG) in patients with Alzheimer's disease (2010) (0)
- 1H-MRS IN SUBJECTS WITH SCD, MCI AND ALZHEIMER'S DISEASE (2016) (0)
- P2-342 A multicenter 1H-MRS study of the medial temporal lobe in MCI and dementia (2006) (0)
- DEPOSITION AND MEMORY PERFORMANCE IN THE DZNE: LONGITUDINAL COGNITIVE IMPAIRMENT AND DEMENTIA STUDY (2018) (0)
- Correction to: Psychotherapeutic interventions in individuals at risk for Alzheimer’s dementia: a systematic review (2022) (0)
- F1-04-03 EFFECTS OFAGE AND TAUMEASURED IN CSF ONMNEMONIC DISCRIMINATION OF OBJECTS AND SCENES IN MEDIAL TEMPORAL LOBE PATHWAYS (2018) (0)
- Study on Organic Triplet Exciton Emission and Quenching Processes by Low-temperature Photo- and Electroluminescence Spectroscopy (2008) (0)
- HARMONIZATION OF SCD OPERATIONALIZATION ACROSS DIFFERENT MEMORY CLINIC SETTINGS: THE EURO-SCD STUDY (2018) (0)
- Violet-to-red photoluminescence of spiro-TAD organic films doped with different organic dyes (2007) (0)
- PREDICTING FUTURE DEMENTIA USING COGNITION, APOE, AND STRUCTURAL MAGNETIC RESONANCE IMAGING: THE ROLE OF WHITE MATTER INTEGRITY (2019) (0)
- Application of Developed APCVD Transparent Conducting Oxides and Undercoat Technologies for Economical OLED Lighting (2011) (0)
- P3-159 Role of glutathione S-transferase omega gene polymorphisms in Alzheimer's disease, vascular dementia and stroke (2004) (0)
- Dispositif électroluminescent organique avec injection ajustable de porteur de charge (2008) (0)
- Risk for dementia in subjective memory impairment, early mild cognitive impairment and late mild cognitive impairment (2012) (0)
- Underlying clusters of NIA‐AA Research Framework stage 2 criteria and their relationship with AD biomarkers in the DELCODE study (2022) (0)
- [Late life depression - Diagnosis, pathophysiology and therapeutic strategies]. (2018) (0)
- Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE) (2018) (0)
- Rare missense variant (R251G) on APOE counterbalances the Alzheimer’s disease risk associated with APOE‐ε4 (2022) (0)
- SUBJECTIVE COGNITIVE DECLINE, AS MEASURED WITH A STRUCTURED INTERVIEW, IS RELATED TO AMYLOID PATHOLOGY IN COGNITIVELY HEALTHY OLDER ADULTS (2018) (0)
- INSPIRATION: results of a cross‐sectional AD risk‐profiling study (2022) (0)
- General practitioners’ opinion on early and pre‐dementia diagnosis of AD: A MOPEAD project survey in five European countries (2020) (0)
- Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease (2018) (0)
- MICROSTRUCTURAL CHANGES IN ALZHEIMER’S DISEASE, MILD COGNITIVE IMPAIRMENT, AND SUBJECTIVE COGNITIVE DECLINE BASED ON MULTICENTER DIFFUSION TENSOR IMAGING: A TBSS ANALYSIS OF DELCODE DATA (2018) (0)
- Correction to: Psychotherapeutic interventions in individuals at risk for Alzheimer’s dementia: a systematic review (2022) (0)
- Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study (2020) (0)
- Soluble TAM receptor biomarkers: Neuroprotection in AD neuroinflammation?" (2022) (0)
- Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohorts. (2023) (0)
- Self‐reflection is associated with markers of Alzheimer’s disease in cognitively unimpaired older adults (2021) (0)
- A PHASE II STUDY EVALUATING EFFICACY, SAFETY, AND TOLERABILITY OF ORAL BI 425809 IN PATIENTS WITH COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE DEMENTIA (2019) (0)
- Using a virtual reality path integration task to investigate entorhinal functioning in individuals with and without subjective cognitive decline (2021) (0)
- An automated, geometry-based method for the analysis of hippocampal thickness (2023) (0)
- Effects of the Vaccine Vanutide Cridificar with QS-21 Adjuvant on Immunogenicity. (2016) (0)
- Speed of cognitive decline in biomarker stratified SCD subgroups (2022) (0)
- Psychotherapeutic interventions in individuals at risk for Alzheimer’s dementia: a systematic review (2022) (0)
- VASCULAR DEMENTIA AND DIETARY PATTERN: A SUBPOPULATION ANALYSIS OF THE ADVENTIST HEALTH STUDY-2 (2018) (0)
- Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease (2020) (0)
- Effects of a mindfulness-based intervention and a health self-management programme on psychological well-being in older adults with subjective cognitive decline: Secondary analyses from the SCD-Well randomised clinical trial (2022) (0)
- Performance comparison of automated white matter lesion segmentation algorithms in the DELCODE Study (2020) (0)
- Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial (2023) (0)
- Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease (2021) (0)
- Automated segmentation of the locus coeruleus in aging and Alzheimer’s disease using 3T neuromelanin‐sensitive MRI (2021) (0)
- Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial (2022) (0)
- The latent dementia phenotype δ is associated with the CSF Alzheimer's disease biomarker signature in subjects with mild cognitive impairment (2015) (0)
- Predementia Counseling (2023) (0)
- MINOR NEUROPSYCHOLOGICAL DEFICITS IN COGNITIVELY NORMAL OLDER INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE: RESULTS FROM THE DELCODE STUDY (2019) (0)
- Alzheimerʼs Disease biomarkers and cortical thickness in persons reporting subjective cognitive decline and healthy controls: Data derived from the DZNE DELCDODE-Study (2020) (0)
- Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers (2019) (0)
- NEUROPSYCHIATRIC SYMPTOMS IN AT-RISK GROUPS FOR AD DEMENTIA AND THEIR RELATION TO AD BIOMARKERS: DATA FROM THE DELCODE STUDY (2018) (0)
- Influence of MR system, field strength and automatic planning routines on Voxel Based Morphometry (VBM) (2008) (0)
- Altered resting state activity associated with anosognosia in Alzheimer's clinical syndrome: Findings from the DELCODE study (2020) (0)
- 1 NIAAA Research Framework : Towards a Biological Definition of Alzheimer ’ s Disease 1 2 draft 11-2 7-17 3 4 (2017) (0)
- EFFECTS OF AGE AND CSF MEASURES OF TAU ON MNEMONIC DISCRIMINATION OF OBJECTS AND SCENES IN MEDIAL TEMPORAL LOBE PATHWAYS (2018) (0)
- Reliability of DTI: A european multicenter study (2010) (0)
- PROGNOSIS OF CLINICAL PROGRESSION IN SUBJECTIVE COGNITIVE DECLINE USING A CLINICAL DECISION SUPPORT SYSTEM (2017) (0)
- IMPROVING BRAIN HEALTH THROUGH AN ONLINE LIFESTYLE PROGRAM: PREFERENCES OF INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE (2017) (0)
- MEMORY IMPAIRMENTAND RISK OF ALZHEIMER’S DEMENTIA IN PEOPLE WITH MCI (2013) (0)
- Artificial neural network visualization methods reveal diagnostically relevant brain regions to detect Alzheimer’s disease: The first step towards comprehensive artificial intelligence (2021) (0)
- P4-084 GENOME-WIDE ASSOCIATION STUDY USING CEREBROSPINAL FLUID BIOMARKERS BETA- AMYLOID-42 AND PTAU181 IN GERMAN SAMPLES OFALZHEIMER’S DISEASE (2012) (0)
- YRP.09 Activation differences in sufficient and insufficient learning – an fMRI study of procedural motor learning (2002) (0)
- Face-name associative recognition is impaired in patients with subjective cognitive decline (2015) (0)
- EFFECTS OF AGE AND TAU MEASURED IN CSF ON MNEMONIC DISCRIMINATION OF OBJECTS AND SCENES IN MEDIAL TEMPORAL LOBE PATHWAYS (2018) (0)
- Two progression patterns in Alzheimer's disease identified from structural MRI in a memory clinic‐based cohort (2022) (0)
- BUPROPION FOR THE TREATMENT OF APATHY IN ALZHEIMER’S DISEASE: A MULTICENTER RANDOMIZED CONTROLLED TRIAL (2019) (0)
- [An unacceptable study]. (2016) (0)
- IMPROVING BRAIN HEALTH THROUGH AN ONLINE LIFESTYLE PROGRAM: PREFERENCES OF INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE (2017) (0)
- 1 In vivo MRI assessment of the human Locus Coeruleus along its rostrocaudal extent in young and older adults (2018) (0)
- P3-069 Reliability of multicenter MRI. Results of a phantom test and in vivo MRI measurement (2004) (0)
- MULTICENTER RESTING STATE FUNCTIONAL CONNECTIVITY IN PRODROMAL AND DEMENTIA STAGES OF ALZHEIMER’S DISEASE: RESULTS FROM THE DZNE DELCODE STUDY (2018) (0)
- Age-related functional changes in domain-speci fi c medial temporal lobe pathways Neurobiology of Aging (2018) (0)
- Subjective memory concerns, objective memory impairment and risk of Alzheimer's dementia in people with MCI (2013) (0)
- IC-P2-141: Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease: A longitudinal study (2008) (0)
- P.0095 Outcome Associated with Suicidality in Inpatients with Symptoms of depression (OASIS-D): Design of a study assessing usual care outcomes (2021) (0)
- Altered resting state activity associatedwith anosognosia in Alzheimer’s clinical syndrome: Findings from theDELCODE study (2020) (0)
- Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood (2019) (0)
- Subject Index Vol. 10, 1999 (1999) (0)
- Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2 (2023) (0)
- Voxel-based morphometry in primary progressive aphasia and its subtypes–data from the multicentric FTLD consortium’s study Germany (2014) (0)
- FREQUENCY OF SUBJECTIVE COGNITIVE DECLINE CRITERIA IN STAGE 2 OF THE NEW NIA-AA FRAMEWORK: A MULTI-COHORT STUDY FROM THE SUBJECTIVE COGNITIVE DECLINE PROFESSIONAL INTEREST AREA (2019) (0)
- Correction: A One-Degree-of-Freedom Test for Supra-Multiplicativity of SNP Effects (2014) (0)
- Characterization of the NIA‐AA Research Framework stage 2 in the longitudinal multicenter DELCODE study (2021) (0)
- RELATIONSHIP BETWEEN LOCUS COERULEUS MRI CONTRAST, COGNITION AND CSF BIOMARKERS IN AGING AND ALZHEIMER’S DISEASE (2018) (0)
- Reduced delay discounting through episodic future imagination in healthy old subjects but not in subjects with subjective cognitive decline: An fMRI study (2015) (0)
- THE ROLE OF SUBJECTIVE COGNITIVE CONCERN IN AGING (2017) (0)
- A 6-items Questionnaire (6-QMD) captures a Mediterranean like dietary pattern and is associated with memory performance and hippocampal volume in elderly and persons at risk for Alzheimer’s disease (2023) (0)
- DOMAIN-SPECIFIC MNEMONIC DISCRIMINATION IN AGEING AND EARLY STAGES OF ALZHEIMER’S DISEASE (2017) (0)
- ‘HEALTHY DIET' AND COGNITIVE STATUS IN THE OLDEST OLD (2016) (0)
- CORTICAL THICKNESS AND ALZHEIMER’S RELATED BIOMARKERS IN SUBJECTIVE COGNITIVE DECLINE - DATA FROM THE DELCODE-STUDY (2019) (0)
- Editorial: Lecanemab: Appropriate Use Recommendations – A Commentary from a European Perspective (2023) (0)
- Evaluation of evidence grades in psychiatry and psychotherapy guidelines (2020) (0)
- HIPPOCAMPAL INTRINSIC CONNECTIVITY SUPPORTS COGNITIVE RESERVE IN AMYLOID-POSITIVE COGNITIVELY NORMAL SUBJECTS AND ALZHEIMER’S DISEASE PATIENTS (2019) (0)
- HIPPOCAMPAL GREY MATTER ATROPHY IS ASSOCIATED WITH THE FREE AND CUED SELECTIVE REMINDING TEST (2014) (0)
- P-129 Cognitive performance and grey matter structure in elderly with subjective memory impairment (2007) (0)
- FACE NAME ASSOCIATIVE RECOGNITION IS ASSOCIATED WITH ALZHEIMER’S DISEASE BIOMARKERS IN PATIENTS WITH SUBJECTIVE COGNITIVE DECLINE (2016) (0)
- [A contribution to the current discussion on anti-dementia drugs in Germany]. (2007) (0)
- Evaluation of the efficacy and safety of orally administered BI425809 during a 12╒week treatment period compared with placebo in patients with cognitive impairment due to Alzheimer╎s disease: Human: Putative therapeutic results for Alzheimers and related dementias (2020) (0)
- Lifelong musical activity is associated with multi-domain cognitive and brain benefits in older adults (2021) (0)
- PHYSICAL AND COGNITIVE ACTIVITY AND RISK OF ALZHEIMER'S DEMENTIA IN SUBJECTIVE COGNITIVE DECLINE AND MILD COGNITIVE IMPAIRMENT (2014) (0)
- IC-P2-105: A multicenter 1H-MRS study of the medial temporal lobe in Alzheimer's disease and mild cognitive impairment (2008) (0)
- Cognitive and biological characteristics of stage 2 of AD in the clinical multicenter DELCODE Study (2020) (0)
- Slowly progressing logopenic aphasia in a patient with a TREM2 (p.T96K) mutation (2015) (0)
- CORRELATION OF CEREBROSPINAL FLUID CYTOKINES WITH CLINICAL MARKERS OF DEMENTIA IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE (2014) (0)
- Non-Pharmacologic Interventions for Older Adults with Subjective Cognitive Decline: Systematic Review, Meta-Analysis, and Preliminary Recommendations (2017) (0)
- Contents Vol. 7, 2010 (2010) (0)
- Smoking upregulates α4β2∗ nicotinic acetylcholine receptors in brainstem and cerebellum (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Frank Jessen?
Frank Jessen is affiliated with the following schools: